Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Achilles Therapeutics Q2 EPS $(0.45)

Achilles Therapeutics (NASDAQ:ACHL) reported quarterly losses of $(0.45) per share.
byBenzinga Newsdesk
August 10, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Achilles Therapeutics (NASDAQ:ACHL) reported quarterly losses of $(0.45) per share.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0